EOS imaging Announces First Results from Clinical Study on Elderly Patients’ Fall Risk Prevention
Study findings correlate the risk of falling with postural balance
measured from EOS exams
PARIS–(BUSINESS WIRE)–EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in
2D/3D orthopedic medical imaging, today announced the first clinical
results from a study designed to determine the correlation between
certain sagittal balance measurements and the risk of falling in elderly
patients. The results of the study will be presented at the French
Rheumatology Congress in Paris, France (December13-15, 2015).
With approximately 30% of the people who are 64 or older falling at
least once a yeari and with people living longer, falls have
become a major public health issue. In 2013, the Center for Disease
Control and Prevention found that direct medical costs for falls in the
U.S. totaled $34 billionii. Fall injuries are among the 20
most expensive medical conditions and result in hospital costs averaging
$35,000.
A study of 122 patients at high risk of falling was conducted by the
Cochin Hospital (Paris) within a collaborative program with EOS imaging
aiming at improving the screening and prevention of falls. The patients
received an EOS exam and clinical parameters associated with postural
alignment were measured with the sterEOS workstation dedicated postural
analysis software. The results of the study showed that specific
parameters are significantly associated with the risk of falling and
could be used to improve the individual assessment of falling risk.
Today, this risk is ascertained by clinical examinations and the
consequent risk of fracture by measuring the bone mineral density.
Professor Christian Roux, Director of the Center for the Evaluation of
Bone Diseases at Cochin Hospital in Paris said, “The prevention of fall
and fracture risk in the elderly is a public health priority and
screening at-risk patients must be simple and reliable. The preliminary
results obtained by the analysis of sagittal balance with EOS are
extremely encouraging, especially in light of this need.”
Marie Meynadier, CEO of EOS imaging said, “The analysis of sagittal
balance and overall posture are emerging as key elements in the
management of diseases related to ageing. The results of this
preliminary study show how EOS systems can be used for the first time in
prevention and screening. We are pleased to see that our solutions are
enabling significant progress in this area.”
The EOS platform provides 2D and 3D full-body, stereo-radiographic
images of patients in functional positions. EOS exams offer a radiation
dose 50% to 85% less than Digital Radiology and 95% less than basic CT
scans. The new EOS Micro Dose system, recently cleared by the Food and
Drug Administration, marks another important step towards the ALARA
principle (As Low As Reasonably Achievable). This latest technology has
made the dose for a pediatric spine follow-up exam equivalent to a
week’s worth of natural background radiation on Earth.
For more information, please visit www.eos-imaging.com.
EOS imaging has been chosen to be included in the new EnterNext©
PEA-PME 150 index, composed of 150 French companies and listed on
Euronext and Alternext markets in Paris.
EOS imaging is listed on Compartment C of Euronext Paris
ISIN: FR0011191766 – Ticker: EOSI
About EOS imaging
EOS imaging designs, develops, and markets EOS®, an
innovative medical imaging system dedicated to osteoarticular
pathologies and orthopaedics, as well as associated solutions. The
Company is authorized to market in 48 countries, including the United
States (FDA), Japan and the European Union (EC). The Group posted 2014
revenues of €20.1 million and employs 107 people including an R&D team
of 39 engineers. The Group is based in Paris and has five subsidiaries
in Besançon (France), Cambridge (Massachusetts), Montreal (Canada),
Frankfurt (Germany) and Singapore.
http://www.cdc.gov/homeandrecreationalsafety/falls/fallcost.html
_____________________
i WHO report http://impremedia-network.go-vip.net/wp-content/uploads/sites/5/2015/12/1.epidemiology_of_falls_in_older_age.pdf
ii
Stevens JA, Corso PS, Finkelstein EA, Miller TR. The costs of fatal and
nonfatal falls among older adults. Injury Prevention 2006a;12:290–5.
Contacts
EOS imaging
Anne Renevot, CFO, +33 (0)1 55 25 61 24
investors@eos-imaging.com
or
NewCap
Financial
communication and investor relations
Pierre Laurent, +33
(0)1 44 71 94 91
eosimaging@newcap.fr
or
The
Ruth Group (US)
Press relations
Joanna Zimmerman,
646-536-7006
jzimmerman@theruthgroup.com
